MicroRNA-210 May Be a Preoperative Biomarker of Malignant Pheochromocytomas and Paragangliomas.

Ruff, Samantha M; Ayabe, Reed I; Malekzadeh, Parisa; Good, Meghan L; Wach, Michael M; Gonzales, Melissa K; Tirosh, Amit; Nilubol, Naris; Pacak, Karel; Kebebew, Electron; Patel, Dhaval

Ruff, Samantha M; Ayabe, Reed I; Malekzadeh, Parisa; Good, Meghan L; Wach, Michael M; Gonzales, Melissa K; Tirosh, Amit; Nilubol, Naris; Pacak, Karel; Kebebew, Electron; Patel, Dhaval.

Afiliação

Ruff SM; Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Ayabe RI; Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Malekzadeh P; Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Good ML; Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Wach MM; Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Gonzales MK; Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland.
Tirosh A; Neuroendocrine Tumors Service, Sheba Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel.
Nilubol N; Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Pacak K; Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland.
Kebebew E; Department of Surgery and Stanford Cancer Institute, Stanford University, Stanford, California.
Patel D; Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Division of Surgical Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin. Electronic address: divot999@gmail.com.

J Surg Res ; 243: 1-7, 2019 11.

Article em En | MEDLINE | ID: mdl-31146085

Assuntos

Neoplasias das Glândulas Suprarrenais/diagnóstico; Biomarcadores Tumorais/sangue; MicroRNAs/sangue; Paraganglioma/diagnóstico; Feocromocitoma/diagnóstico; Neoplasias das Glândulas Suprarrenais/sangue; Neoplasias das Glândulas Suprarrenais/patologia; Neoplasias das Glândulas Suprarrenais/cirurgia; Adulto; Feminino; Seguimentos; Humanos; Modelos Logísticos; Masculino; Pessoa de Meia-Idade; Paraganglioma/sangue; Paraganglioma/patologia; Paraganglioma/cirurgia; Feocromocitoma/sangue; Feocromocitoma/patologia; Feocromocitoma/cirurgia; Projetos Piloto; Cuidados Pré-Operatórios; Período Pré-Operatório; Prognóstico; Estudos Prospectivos; Reação em Cadeia da Polimerase em Tempo Real; Reação em Cadeia da Polimerase Via Transcriptase Reversa

Palavras-chave

Adrenal; Malignancy; MicroRNA; Paraganglioma; Pheochromocytoma; miR-210

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Paraganglioma / Feocromocitoma / Biomarcadores Tumorais / Neoplasias das Glândulas Suprarrenais / MicroRNAs Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Surg Res Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google